CO-KARBIS 16mg / 2.5mg tablets medication leaflet

C09DA06 candesartan cilexetil + indapamide • Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics

Candesartan cilexetil and indapamide are used together for the treatment of high blood pressure, providing more effective blood pressure control. This combination combines an angiotensin II receptor antagonist (candesartan) and a thiazide-like diuretic (indapamide).

Candesartan helps relax blood vessels, while indapamide reduces blood volume by increasing the elimination of water and salt through urine. This leads to lower blood pressure and a reduced risk of cardiovascular complications.

The medication is taken orally, usually once daily, as directed by a doctor. It is important to monitor blood pressure and electrolyte levels during treatment.

Side effects may include dizziness, fatigue, electrolyte imbalances, or, in rare cases, allergic reactions. Patients should inform their doctor of any unusual symptoms.

General data about CO-KARBIS 16mg / 2.5mg

Substance: candesartan cilexetil + indapamide

Date of last drug list: 01-03-2025

Commercial code: W70913013

Concentration: 16mg / 2.5mg

Pharmaceutical form: tablets

Quantity: 56

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: KRKA D.D., NOVO MESTO - SLOVENIA

Holder: KRKA, D.D., NOVO MESTO - SLOVENIA

Number: 15815/2025/13

Shelf life: 2 years

Concentrations available for candesartan cilexetil + indapamide

16mg/2.5mg, 8mg/2.5mg

Other substances similar to candesartan cilexetil + indapamide